Keyphrases
Schizophrenic Patients
65%
Schizophrenia
52%
Antipsychotics
19%
Electroconvulsive Therapy
19%
Obsessive-compulsive Disorder
17%
Comorbid
15%
Akathisia
15%
Trazodone
14%
Corneal Temperature
14%
Olanzapine
14%
Benign Paroxysmal Positional Vertigo
14%
Patients with Schizophrenia
14%
Psychosis
11%
Selective Serotonin Reuptake Inhibitors
11%
Amantadine
10%
Mental Status
10%
Negative Syndrome
9%
Treatment-resistant Schizophrenia
9%
Augmentation Therapy
9%
Donepezil
9%
Clozapine
9%
Dehydroepiandrosterone
9%
Escitalopram
9%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
9%
Negative Symptoms
8%
Placebo
8%
Drug-free
7%
Psychotic
7%
Psychotic Patients
7%
Obsessive-compulsive
6%
Obsessive-compulsive Symptoms
6%
Israel
6%
DSM-IV
6%
Psychiatric Disorders
6%
Aggression
6%
Depressive Symptoms
6%
Monotherapy
6%
Treatment-resistant Depression
5%
Major Depressive Disorder
5%
Extrapyramidal Symptoms
5%
Placebo-controlled
5%
Dizziness
5%
Beneficial Effects
5%
Blood Pressure
5%
Randomized Placebo-controlled Trial
5%
Cannabis
5%
Double-blind Placebo-controlled Trial
5%
High Dose
5%
Neuroscience
Dementia Praecox
100%
Typical Antipsychotic
32%
Electroconvulsive Therapy
19%
Obsessive-Compulsive Disorder
17%
Placebo
16%
Selective Serotonin Reuptake Inhibitor
15%
Akathisia
15%
Trazodone
14%
Negative Syndrome
13%
Positive Syndrome
11%
Psychosis
10%
Amantadine
10%
Treatment-Resistant Schizophrenia
9%
Donepezil
9%
Platelet
9%
Clozapine
9%
Dehydroepiandrosterone
9%
Crossover Study
9%
Escitalopram
9%
Mental Disorder
9%
Antidepressant
8%
Antipsychotic
6%
Serotonin
6%
Cannabis
5%
Behavior (Neuroscience)
5%
Major Depressive Disorder
5%
Parkinson's Disease
5%
Reuptake Inhibitor
5%
Extrapyramidal Symptoms
5%
Pharmacology, Toxicology and Pharmaceutical Science
Typical Antipsychotic
27%
Placebo
18%
Antipsychotic
18%
Akathisia
15%
Trazodone
14%
Olanzapine
14%
Symptom
14%
Negative Syndrome
10%
Donepezil
9%
Selective Serotonin Reuptake Inhibitor
9%
Amantadine
9%
Prasterone
9%
Obsessive Compulsive Disorder
7%
Positive Syndrome
7%
Disease
7%
Prevalence
6%
Psychosis
6%
Symptomatology
6%
Monotherapy
6%
Cannabis
5%
Serotonin
5%
Extrapyramidal Symptoms
5%
